Tag: Cancer Research
-
Inflammation Drives Early Lung Cancer: MD Anderson Maps
New Insights into the Onset of Lung Cancer Researchers at The University of Texas MD Anderson Cancer Center have unveiled a landmark approach to understanding how lung cancer begins. By creating high-resolution cellular and molecular maps of lung tissue before and during cancer development, the team shows that chronic inflammation may be a primary driver…
-
Inflammation identified as a key driver in the earliest stages of lung cancer
New insights point to inflammation as a trigger in early lung cancer Researchers at The University of Texas MD Anderson Cancer Center have unveiled high-resolution cellular and molecular maps that illuminate how inflammation may initiate lung cancer in its earliest stages. The study, which charts the lung’s microenvironment before and during tumor development, suggests that…
-
Unraveling Immunotherapy Resistance in Kidney Cancer: The Role of Myeloid Cell Signaling
Overview: Immunotherapy and the Challenge in Advanced Kidney Cancer Immunotherapy has transformed treatment for many cancers, including renal cell carcinoma (RCC). Yet a significant subset of patients with advanced RCC experience limited benefit due to intrinsic or acquired resistance. A recent research focus centers on the tumor microenvironment, where immune and myeloid cells communicate in…
-
New Nanoparticles Stimulate the Immune System to Attack Ovarian Tumors
Reframing Immunotherapy for Ovarian Cancer Immunotherapy has transformed cancer treatment by empowering the body’s own defender — the immune system — to recognize and destroy tumor cells. Yet ovarian cancer has proved streaky ground for many immunotherapies, with tumors often adept at cloaking themselves from immune detection. Recent advances, however, suggest that nanoscale delivery systems…
-
Nanoparticle Breakthrough: A New Strategy to Activate the Immune System Against Ovarian Tumors
New Nanoparticles Spark Immune Response Against Ovarian Tumors Researchers are turning to nanotechnology to overcome a long-standing challenge in cancer immunotherapy: how to effectively stimulate the immune system to recognize and destroy ovarian tumors. A new class of nanoparticles is showing promise by delivering immune-activating signals directly to tumor sites and modulating the tumor microenvironment…
-
Nanoparticles Boost Immune Attack on Ovarian Tumors
New nanoparticle approach aims to strengthen immunotherapy for ovarian cancer Cancer immunotherapy has transformed treatment for several tumor types, but its success with ovarian cancer has been limited. Recent research explores a novel class of nanoparticles designed to prime the immune system and improve anti-tumor responses specifically in ovarian tumors. By delivering immune-stimulating signals directly…
-
Dormant BRAF Mutations in Healthy Skin Challenge Melanoma Screening Assumptions
New findings reshape how we think about melanoma risk A recent study from researchers at the University of Queensland is prompting scientists and clinicians to rethink a long-held belief about how melanoma develops. The team has identified a genetic mutation in the BRAF gene that can lie dormant in healthy skin for years before potentially…
-
Study challenges conventional wisdom on a common cause of melanoma
New clues about melanoma risk from an unlikely place Melanoma, the deadliest form of skin cancer, has long been associated with visible sun damage and a specific set of genetic mutations. Among these, changes in the BRAF gene have been a focal point for researchers and clinicians alike. A recent study from the University of…
-
Could COVID Vaccines Help Fight Cancer? What the New Findings Mean
Could the COVID-19 vaccine help in the fight against cancer? Emerging research is stirring new questions about how COVID-19 vaccines, particularly mRNA vaccines, might interact with cancer therapies. A study analyzing more than 1,000 patient records suggests that receiving a COVID-19 mRNA vaccine within 100 days of starting immunotherapy was associated with longer survival for…
-
Biologic Sex and Obesity Influence Post-Surgical Outcomes in Pancreatic Cancer, Study Finds
Overview: A Novel Look at Sex, Obesity, and Pancreatic Cancer Outcomes A recent observational study published in Cancer highlights how biologic sex and obesity may shape liver recurrence and overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC) who undergo upfront surgical resection. Analyzing a large cohort treated at Memorial Sloan Kettering Cancer Center…